BioWorld-International-2003-05-21
Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect
Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect
LONDON - Chiron Corp. plans to acquire PowderJect Pharmaceuticals plc in an agreed-to cash offer valuing the vaccines manufacturer at £542 million (US$878 million). (BioWorld International)

